Amorolfina Stada

Quick links

Choose a section

Quick links to important sections

Advertisements

Amorolfina Stada

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Amorolfina Stada

Property Description
Active ingredient Amorolfine (as hydrochloride)
Form Medicated Nail Lacquer (Solution)
Pharmacological Class Morpholine Antifungal / Antimycotic
Route of Administration Topical, Local Action
Origin Synthetic Compound

Amorolfina Stada: An Overview of Type and Origin

Amorolfina Stada is formally classified as a potent topical antifungal agent containing the active ingredient Amorolfine (as the hydrochloride salt). This substance is clinically recognized for its focused action against localized fungal infections of the nail. Amorolfine belongs to the morpholine antifungal class (ATC code D01AE16). It is a structurally unique synthetic compound, chemically distinct from the widely known azole and allylamine classes, placing it within the broader Antimycotic pharmacological category. This medicinal entity is strictly a single-component product designed for focused action.

Composition and Targeted Delivery as a Medicated Nail Lacquer

This medicine is provided in the specific dosage form of a medicated nail lacquer (solution), which is strictly applied via the topical route for local action on the nail plate. The formulation typically contains Amorolfine at a concentration of 5% w/v as the sole active ingredient, suspended within a solvent-based vehicle. The physical presentation as a lacquer is integral to its function, utilizing a film-forming vehicle to ensure the active substance penetrates the hard nail structure and diffuses into the underlying nail bed, where the fungal infection is established. This localized strategy ensures high drug concentration at the fungal site.

General Purpose and Fundamental Mode of Action

The general therapeutic purpose of Amorolfina Stada is to combat and eliminate fungal organisms and clear superficial fungal infections, particularly those affecting the nail. The medicine achieves this by critically compromising the fungal cell membrane's structural integrity. Amorolfine interferes with the synthesis of ergosterol, the substance essential for fungal cell maintenance, leading to defects. This targeted interference imparts both a fungicidal effect (killing the fungus) and a fungistatic effect (preventing reproduction), providing comprehensive control over fungal proliferation.

Advertisements

What side effects are possible with Amorolfina Stada?

Possible side effects and safety information

The safety profile of Amorolfina Stada is established by its topical application and low systemic absorption, with adverse reactions documented as predominantly localized to the treatment area.

Adverse reactions are classified according to official frequency standards:

Frequency System Organ Class Documented Reactions
Rare (up to 1 in 1,000) Skin and Subcutaneous Tissue Disorders Nail damage, nail discolouration, fragile or brittle nails.
Very Rare (up to 1 in 10,000) Skin and Subcutaneous Tissue Disorders Skin burning sensation.
Not Known (frequency cannot be estimated) Immune System Disorders Systemic Allergic Reaction (Hypersensitivity), including swelling of the face, difficulty breathing, and severe skin rash.
Not Known Skin and Subcutaneous Tissue Disorders Redness (erythema), itching (pruritus), contact dermatitis, urticaria, and blisters.

Serious Adverse Reactions

Official regulatory documents note the potential for a Systemic Allergic Reaction (Hypersensitivity), which is considered a serious event, though its frequency is classified as Not Known. This reaction is categorized under Immune System Disorders and may occur outside the direct application site.

Safety Restrictions and Population Considerations

The label includes specific safety constraints. The medicine is contraindicated in individuals with known hypersensitivity to the active substance or any excipients. Use is not recommended in children and adolescents due to insufficient clinical experience. As a precautionary measure, use should be avoided during pregnancy and lactation due to limited human data. Additionally, the product contains ethanol, and contact with the eyes, ears, or mucous membranes must be avoided.

Advertisements

Overdose and Emergency Response

The official regulatory documents define the overdose profile of Amorolfina Stada primarily by the low exposure risk associated with its topical use as a medicated nail lacquer. Due to the minimal systemic absorption of the active ingredient, no systemic signs of overdose are expected following the intended application of the product.


Accidental Ingestion and Emergency Actions

In the event of accidental oral ingestion, official prescribing information mandates that the individual contact a doctor, pharmacist, or nearest hospital straight away. For cases of oral intake, regulatory documents describe that appropriate symptomatic measures should be taken if necessary, and an appropriate method of gastric emptying may be used as a procedural step. No specific antidote is explicitly documented.

Severe Manifestations Requiring Urgent Help

A separate requirement for urgent medical help exists for a systemic allergic reaction (hypersensitivity) that may occur after application. Clinical manifestations of this severe event can be associated with swelling of the face, lips, tongue or throat, difficulty breathing (respiratory problems), and/or a severe skin rash. Should any of these manifestations occur, the product must be stopped immediately and urgent medical help must be sought.

Advertisements

Therapeutic Uses of Amorolfina Stada

What Amorolfina Stada Treats: Main Uses and Benefits

Amorolfina Stada is a specialized topical treatment primarily indicated for the mycological clearance of fungal infections of the nail, clinically termed onychomycosis, in adults. It is commonly used for infections caused by certain pathogens, including dermatophytes, yeasts, and moulds. This treatment is relevant in conditions where the infection is localized and without nail matrix involvement.

It is applied in situations involving certain distressing symptoms related to aesthetic and structural nail damage, helping to address noticeable issues like pronounced thickening, brittleness, and discoloration. The key therapeutic benefit plays a role in managing the fungal pathogens and is relevant for easing symptoms related to physical discomfort, contributing to the growth of uninfected nail.

“The therapeutic approach supports the patient in maintaining a sense of stability when symptoms are more noticeable and offers supportive relief, especially for adults seeking a localized treatment option.”

This localized therapy is often used when supportive symptom management is appropriate for persistent or recurrent fungal contamination, helping to maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Aesthetic and Structural Nail Damage

The medication plays a role in managing the fungal pathogens, which assists with contributing to the growth of nail tissue that appears less affected and supports general well-being during symptomatic periods.


Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Amorolfina Stada: Official Regulatory Information

The eligibility for Amorolfina Stada (Amorolfine 5% Medicated Nail Lacquer) is determined by regulatory bodies based on age, physiological status, and underlying health conditions.

Category Official Regulatory Statement
Populations for whom use is allowed Adults (aged 18 years and over) and the Elderly [2.3, 3.1].
Populations for whom use is contraindicated Individuals with known hypersensitivity to the active substance, amorolfine, or any component of the lacquer [2.3, 2.5].
Age-related eligibility rules Not recommended for use in children and adolescents under 18 years due to a documented lack of clinical experience and insufficient data in this population [2.3, 3.2].
Pregnancy and lactation eligibility status Not recommended during pregnancy or breastfeeding unless clearly necessary, due to limited human data [2.4, 2.8].
Eligibility-related restrictions Patients with diabetes, poor blood circulation (peripheral vascular disease), weakened immune systems, or severely damaged nails should seek medical advice before use [2.1, 3.1].

Regulatory documents establish the sole absolute non-eligibility rule as hypersensitivity. Standard use is explicitly cleared for adults, while use is formally restricted for pediatric patients and high-risk populations due to data limitations or predisposing medical conditions.

Advertisements

What should I know about interactions with other medicines?

The official interaction profile for Amorolfina Stada is determined by its formulation as a topical medicated nail lacquer, resulting in extremely low systemic absorption of the active ingredient, Amorolfine. Regulatory documents consistently indicate minimal potential for conventional drug–drug interactions.

Interaction Status with Systemic Medicines

Interaction Type Official Regulatory Statement
Drug–Drug Interactions No interaction studies have been performed; no known interactions with other medicines exist.
Metabolic/PK Effects No documented statements regarding CYP-mediated, transporter-based, or exposure-altering interactions.

Substance and Administration Constraints

The documented restrictions relate to maintaining the physical layer of the lacquer, which is essential for the product's effectiveness:

  • Cosmetic Nail Products: A timing separation is mandatory when applying cosmetic nail varnish. The cosmetic product must be applied at least 10 minutes after the medicated lacquer has been applied and allowed to dry. The cosmetic varnish must be completely removed before the next scheduled application of Amorolfina Stada.
  • Organic Solvents: Impermeable gloves must be worn when handling organic solvents, such as thinners or white spirit, as these substances can physically remove the film of the medicated nail lacquer.
Advertisements

Mechanism of Action

How Amorolfina Stada Works

The mechanism of action of Amorolfine is a highly targeted process focused on compromising the fungal cell's essential structural components. This action is defined by a specific molecular cascade that leads to the organism's functional failure.

Dual-Level Inhibition of Fungal Sterol Synthesis

The drug's primary action involves acting as an inhibitor on two different, critical enzymes within the fungal ergosterol biosynthesis pathway: the Delta14-reductase and the Delta7- Delta8-isomerase. This concerted, two-point blockade prevents the synthesis of ergosterol, the substance fungi require to build and maintain their cell membranes. This molecular disruption is the initial step that establishes the drug's fungicidal action.

Membrane Sabotage and Cell Disintegration

As a direct consequence of the enzyme blockade, abnormal, non-functional sterols (like ignosterol) are created and incorporated into the fungal cell membrane, replacing the necessary ergosterol. This incorporation compromises the membrane's structure, causing a massive increase in its permeability and fragility. This physiological breakdown leads directly to the fungicidal effect (cell death) and fungistatic effect (growth arrest), which suppresses fungal proliferation and viability.

Sustained Local Concentration for Mechanistic Efficacy

The formulation is designed to ensure the active ingredient achieves and maintains high concentrations at the site of fungal activity. This prolonged, localized exposure is a necessary mechanistic factor that ensures drug levels remain high enough over time to continuously override the fungal cell's attempts to repair its sterol synthesis pathway, leading to a sustained fungicidal and fungistatic response.

Advertisements

Dosage and Administration Information

Application Procedure

Amorolfina Stada is a medicated nail lacquer intended for topical application to affected fingernails or toenails. The process involves specific steps to ensure the lacquer is applied to a clean and prepared surface.

Preparation of the Nail

Before the first application, it is necessary to clean the affected nails thoroughly. Any previous layers of lacquer should be removed using a cleansing swab or nail polish remover. Following this, the surface of the nail, particularly the affected areas, should be filed down as much as possible using a disposable nail file. This helps to remove infected tissue and create a rougher surface for better adherence.

Cleaning the Surface

Once the filing is complete, the nail surface must be cleaned and degreased. This is typically done using a dedicated cleansing swab. This step ensures that no filing residue or oils remain on the nail, which could interfere with the application of the medicated lacquer.

Applying the Lacquer

The lacquer is applied evenly over the entire surface of the affected nail using a reusable applicator or spatula. It is important to let the lacquer dry completely after application. This drying process usually takes a few minutes.

Maintenance of Tools

To prevent cross-contamination or the spread of infection, the tools used during the process require careful handling:

  • Disposable Files: Nail files used on affected nails should not be used on healthy nails and should be discarded after use.
  • Applicators: The reusable applicator must be cleaned thoroughly after each application session, typically with a cleansing swab, before being placed back into the bottle.
  • Cleaning Swabs: Used swabs should be disposed of safely.

Cosmetic Use and Hygiene

While using the medicated lacquer, the use of cosmetic nail polish or artificial nails is generally not recommended as it may interfere with the efficacy of the lacquer. If multiple nails are affected, the same application process is followed for each. Hands should be washed thoroughly after the procedure if the fingernails themselves were not the target of the application.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies


Core Efficacy Research

Studies investigated the basis for the drug's activity. The research investigated the compound's effect on nail fungal infections, specifically onychomycosis (fungal infection of the nail). Clinical trials of amorolfine 5% nail lacquer have reported outcomes in patients with mild to moderate infection without matrix involvement.

Research has examined the therapeutic effect across different study populations. In these trials, once- or twice-weekly applications for up to six months have been investigated. Mycological and clinical cure rates, typically evaluated three months after stopping therapy, were reported in a range of approximately 40% to 55% in patients with mild onychomycosis.


Research in Specific Populations and Safety

Research has explored the tolerability profile of the topical lacquer. Due to the minimal systemic absorption of amorolfine when applied topically, systemic side effects were rarely observed in clinical studies. Adverse events reported were generally localized, consisting mainly of minor skin or nail-related reactions at the application site.

Studies did not evaluate the safety or efficacy of this treatment in children, or during pregnancy and breastfeeding, due to a lack of clinical data in these populations. The evidence suggests that for effective treatment, the duration often needs to be maintained until the entire infected nail has grown out.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amorolfina Stada (FAQ)

Q: How long does it usually take to see the first visible improvement in the nail?

Because nails naturally grow slowly, patient information states that it typically takes a couple of months, usually two to three, before a visible improvement in the infected nail becomes apparent. Official information emphasizes that the full duration of treatment, as described in the official documents, is necessary for resolution.

Q: Why does the treatment for nail fungus take so long with Amorolfina Stada?

The long treatment duration, typically ranging from 6 to 12 months, is due to the natural rate of nail growth. The application schedule described in official documents requires that treatment continues until the entire infected nail has grown out completely and been replaced by healthy nail tissue.

Q: What is the difference between the effectiveness on toenails versus fingernails?

Official treatment guidelines note that the duration required is longer for toenails, typically 9 to 12 months, compared to 6 months for fingernails. This difference is linked to the generally slower natural growth cycle of toenails. Studies suggest that factors affecting the nail's growth rate and the drug's localized concentration may influence the final outcome.

Q: What happens if treatment with Amorolfina Stada is stopped too early?

Regulatory information emphasizes that the treatment regimen is based on continuous use until the infection has fully cleared and a completely healthy nail has grown back. Stopping the application schedule before the infection is resolved carries the risk of the fungal infection returning or relapsing.

Q: What are the official signs that the nail infection is completely cured?

Official information indicates that the infection is considered cured when the treated nail has grown out fully and appears completely healthy. This outcome, which involves both clinical appearance and often a negative fungal test, is typically evaluated by a healthcare professional.

Q: Are there clinical study results on the long-term effectiveness of Amorolfina Stada?

Studies have been conducted to examine the long-term effectiveness of the nail lacquer. Research reports outcomes such as clinical and mycological cure rates in a range of approximately 40% to 55% in patients with mild onychomycosis, typically evaluated months after stopping therapy. Recurrence rates were also examined in the available evidence.

Q: What factors might affect how well Amorolfina Stada works?

Official documents and research suggest that the effectiveness of the treatment can be influenced by several factors. These include the overall severity of the infection, adherence to the specified application schedule, and the presence of underlying health conditions in the patient.

Q: Is Amorolfina Stada effective against all types of fungi that cause nail infections?

The active ingredient, Amorolfine, is classified as a broad-spectrum fungicidal agent. Official pharmacology documents describe it as active against a wide variety of the dermatophytes, yeasts, and molds that are commonly known to cause nail infections.

Q: Can Amorolfina Stada be used for other types of skin or foot fungus?

The medicine is strictly indicated for the treatment of fungal infections of the nails, known as onychomycosis. While the active ingredient is a broad-spectrum antifungal agent active against common fungi, the product's formulation as a nail lacquer is designed only for local action on the nail plate itself.

Q: Is it mandatory to treat athlete's foot (tinea pedis) at the same time as the nail infection?

While Amorolfina Stada is indicated only for the nail infection, official clinical information suggests that simultaneously treating other nearby fungal infections, such as athlete's foot (tinea pedis), may help reduce the risk of recurrence or re-infection of the nail.

Q: Is there a reason some doctors suggest twice-weekly application instead of once-weekly?

Regulatory documents state that the standard regimen involves application once weekly. However, the product's official prescribing information mentions that twice-weekly application may be considered by a healthcare professional based on their evaluation of clinical necessity or the patient's individual circumstances.

Q: How long does the lacquer take to dry after application?

After applying a thin coat to the nail surface, the product label states that the treated nail(s) should be allowed to air dry completely. The manufacturer's instructions state that this process takes approximately three minutes.

Q: Is it safe to wash my hands or feet immediately after the lacquer has dried?

According to the official product information, once the lacquer has dried on the nail (a process that takes about three minutes), the product is described as being unaffected by soap and water after the drying time has passed.

Q: Can a cosmetic nail polish be applied over Amorolfina Stada?

Yes, a cosmetic nail varnish can be applied, but official instructions require a mandatory waiting period of at least 10 minutes after the medicated lacquer has dried. The cosmetic polish is required to be completely removed before the next scheduled application of Amorolfina Stada.

Q: Can I use hand sanitizer on my nails after the lacquer has dried?

Official warnings advise wearing impermeable gloves when handling organic solvents, such as paint thinners, as these can physically remove the medicated film from the nail. While hand sanitizers are not specifically named, this precaution is intended to preserve the lacquer layer on the nail.

Q: Should the whole nail or only the infected parts be filed down before use?

Official instructions describe that before each application, the affected nail surface, including the visibly infected areas, is filed down. This preparatory step is required to help the active ingredient penetrate the nail structure.

Q: How can I avoid spreading the fungal infection to healthy nails while using Amorolfina Stada?

Official advice states that nail files used on the infected nail should not be used on healthy nails or skin, and should not be shared with other people. This is one of the strict hygiene measures intended to prevent the spread of infection.

Q: What precautions are necessary when handling the nail files and applicators?

Patient information specifies that the applicators are to be cleaned thoroughly with the provided cleaning swab after each use. To prevent the spread of fungus, nail files used on the affected nails are not used on healthy nails or shared.

Q: What if the lacquer bottle is left open by accident?

The storage instructions require the bottle to be kept tightly closed immediately after use to prevent the product from hardening or deteriorating due to solvent evaporation. If the medicine is found to have hardened, regulatory requirements indicate that it should be discarded via established local procedures.

Q: Can Amorolfina Stada be used if the skin around the nail is already irritated?

Patients are advised to take care to avoid getting the medicated lacquer on the skin surrounding the nail. Redness (erythema), itching (pruritus), and contact dermatitis are documented as possible side effects that may occur at or around the application site.

Q: Can Amorolfina Stada cause the nail to fall off?

Documented side effects of the medicine include localized nail damage, fragile nails, and nail discolouration. Official documents do not explicitly state that the medicine itself causes the entire nail to separate or fall off.

Q: What signs might indicate a systemic or serious allergic reaction to Amorolfina Stada?

A serious event classified in official documents as a Systemic Allergic Reaction (Hypersensitivity) may present with signs like swelling of the face, lips, tongue, or throat, difficulty breathing, or a severe skin rash appearing away from the area of application. The frequency of this reaction is classified as Not Known.

Q: What happens if Amorolfina Stada is accidentally ingested?

Official safety information states that the medicine is required to be kept out of the sight and reach of children due to the risks associated with accidental ingestion. If the product is swallowed, regulatory documents advise that immediate medical attention is sought.

Q: What should be done if Amorolfina Stada accidentally gets into the eye or mouth?

The product label states that contact with the eyes, ears, or mucous membranes is to be strictly avoided. If accidental contact occurs, the official guidance describes washing the affected area immediately and thoroughly with water.

Q: What is the guidance for using Amorolfina Stada in older adults?

According to official regulatory documents, older adults are advised to follow the standard adult administration regimen. There are no specific dose adjustments or constraints detailed for the elderly population regarding the use of this medicine.

Q: What restrictions apply to individuals with compromised immune systems?

The official eligibility criteria advise that individuals with certain predisposing medical conditions, such as a weakened or compromised immune system, is specified that medical advice from a healthcare professional is sought before use.

Advertisements

How should Amorolfina Stada be stored and disposed of?

Official Storage and Disposal Requirements

This medicine must be handled and stored strictly according to the rules defined in its regulatory documentation to maintain its quality and ensure safety.

Requirement Area Official Rule
Temperature & Flammability Store the product below 30 C and keep it away from heat, fire, or flames, as its alcohol base is noted as inflammable.
Container & Stability Keep the bottle tightly closed immediately after use to prevent deterioration. The medicine must be discarded if it has hardened. The shelf life after first opening is typically 6 to 9 months, depending on the pack size.
Child Safety It is mandatory to keep this medicine out of the sight and reach of children.
Disposal Do not dispose of unused or expired medicine in household waste or wastewater. Disposal must be done via a pharmacist or specialized collection point in accordance with local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amorolfina Stada found in:

A-Z Index: